TY - JOUR AU - Tanaka PY - 2019 DA - 2019// TI - Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan JO - Arthritis Res Ther VL - 21 UR - https://doi.org/10.1186/s13075-019-1856-4 DO - 10.1186/s13075-019-1856-4 ID - Tanaka2019 ER -